Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

LIDOCAINE HYDROCHLO

Active
SPE2DP-26-T-4237Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

423450 - Medical, Dental, and Hospital Equipment and Supplies Merchant WholesalersView NAICS

Place of Performance

5250 GIBSON AVE BLDG 5250, JBER, AK, 99506-4400, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4237.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts

Full Description

Show more
LIDOCAINE HYDROCHLO
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, USP. RX ONLY<(>,<)>
ADMINISTERED PARENTERALLY BY INJECTION. CONTAINS 2 PERCENT CONCENTRATION
OF LIDOCAINE HYDROCHLORIDE AND 1:50,000 DILUTION OF EPINEPHRINE (AS THE
BITARTRATE). 1.7 ML CARTRIDGE, 50'S. UNIT OF ISSUE IS A PACKAGE
CONTAINING 50 SINGLE DOSE CARTRIDGES (SUPPLIED IN CARDBOARD BOXES
CONTAINING 5 BLISTERS OF 10 X 1.7 ML CARTRIDGES). STORE AT CONTROLLED
ROOM TEMPERATURE, BELOW 25°C (77°F). PROTECT FROM LIGHT. DO NOT PERMIT
TO FREEZE.
...
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS013: Shelf-life requirement RS001 for a TYPE I (CODE K) item with a shelf life of 18 months (non-extendable) applies to this item.
... SHALL BE MARKED IAW THE LATEST EDITION OF THE MEDICAL MARKING STANDARD NO. 1. MMS NO. 1 IS AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
BENCO DENTAL SUPPLY CO. 1V865 P/N 4116-609 DENTSPLY SIRONA INC 0KSX4 P/N 22216 DENTSPLY SIRONA INC 0KSX4 P/N NDC66312-0181-16
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-4237
SECTION B
PR: 7017577604 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017577604 0001 PG 1.000
NSN/MATERIAL:6505015762767
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:A
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:Z PACKING LEVEL: B
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
PARCEL POST ADDRESS:
FM5000
FM5000 673 MDSS SGSM
5250 GIBSON AVE BLDG 5250
JBER AK 99506-4400
US
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
SPE2DP-26-T-4237
SECTION B
PR: 7017577604 PRLI: 0001 CONT’D
FREIGHT SHIPPING ADDRESS:
FM5000
FM5000 673 MDSS SGSM
CP 907 552 8846
5250 GIBSON AVE BLDG 5250
JBER AK 99506
US
M/F: (TCN) FM500062010582
RDD:
PROJ: TP 1
SUPP ADD: SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 03
DIC: A01 DIST: ADV: 2A FC: 6B
Need Ship Date:00/00/0000 Original Required Delivery Date:07/24/2026
SPE2DP-26-T-4237 NSN/Part Number: 6505-01-576-2767 Quantity: 1 PG Purchase Request: 7017577604QTY: 1 Delivery: 5 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 423450
New
DIBBS
RESUSCITATION KIT, MOUTThe resuscitation kit is a pediatric-specific, latex-free Brosewell Hinkle system designed for emergency use, containing a complete set of essential resuscitation components including two procedural modules in seven pouches, a Broselow tape, two manual resuscitators, four cuff masks, three disposable blood pressure cuffs, one gauge, two Magill forceps, and two laryngoscope handles. It is configured as a comprehensive mouth-to-mask or oronasal resuscitation solution intended for rapid deployment in critical care scenarios. The kit must have a minimum 24-month shelf life, with no more than three months elapsed from the date of manufacture to the date of government delivery, ensuring freshness and operational readiness upon receipt. Each kit is identified by NSN 6515-01-513-9276 and must be labeled with the manufacturer’s name and CAGE code, date of manufacture, expiration or retest date, and contract or lot number. The kit complies with DLA packaging requirements and technical standards referenced under RA001, RP001, and RQ011, ensuring adherence to federal procurement protocols. The contract solicitation number is SPE2DS-26-T-259Y, with a 20-day delivery window following award, and the item is to be delivered to Binghamton, NY, under a federal acquisition by the Department of Defense, Medical Supply Chain, as part of a single-unit purchase under purchase request 7017570635.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 19 hours ago

DEADLINE

in 5 days
View Details
NAICS: 423450
New
DIBBS
BOTTLE, SCREW CAPThe contract specifies the procurement of a single cylindrical 4 oz (120 ml) bottle with a screw cap, identified by NSN 6640-00-500-0276 and Millipore part number XX65-047-09, with no substitutions allowed. The item is made of clear bluish-pink tinted polyvinylidene chloride (PVC) and is not regulated by the FDA. Packaging must comply with DLA Packaging Requirements for Procurement (RP001), requiring each unit to be sealed in a protective container that prevents damage during handling, and all shipments must use commercially suitable exterior containers for safe delivery via common carrier at the lowest rate to the destination. Marking must conform to Medical Marking Standard No. 1, superseding MIL-STD-129, and packaging must adhere to ASTM D3951 unless the item is hazardous under FED-STD-313, in which case IP025 requirements apply. All DLA Master List of Technical and Quality Requirements take precedence over general commercial standards. The unit of issue is each (EA), with a quantity of one unit, delivered FOB destination within 20 days of contract award. Delivery is to Marine Aviation Logistic Squadron MALS-24 at MCAS Kaneohe Bay, Hawaii, with freight and parcel post addresses provided. The purchase request number is 7017575437, and the solicitation number is SPE2DH-26-T-5396 with a response deadline of July 29, 2026, and an original required delivery date of July 24, 2026.
MEDICAL SUPPLY CHAIIN FSH

POSTED

about 19 hours ago

DEADLINE

in 7 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 325412
New
DIBBS
ZINC OXIDE OINTMENTZinc Oxide Ointment USP, a topical skin protectant containing 20% zinc oxide, is provided in collapsible tubes of 28.35 grams, with the unit of issue designated as a tube (TU). The product is regulated by the FDA and must comply with strict technical and quality requirements outlined in the DLA Master List of Technical and Quality Requirements, including packaging standards under MIL-STD-129 and commercial packaging per ASTM D3951 when non-hazardous, with DLA requirements superseding all other standards. Labeling must adhere to the latest Medical Marking Standard No. 1, and shelf life is fixed at 36 months without extension. Storage requires controlled room temperature not exceeding 30°C (86°F). The ointment is supplied by DYNAREX CORP under NDC 67777-0223-11 and part number 1190, with traceable shipping mandated and parcel post prohibited. Two delivery lines are specified: three tubes to Morrisville, NC with a July 24, 2026 delivery deadline and six tubes to Fort Bragg, NC with a July 27, 2026 deadline, both delivered FOB destination with zero quantity variance permitted. Inspection and acceptance occur at the delivery point, and packaging must meet DLA's RP001 packaging and palletization requirements. All shipments must include government-identifying information per contract specifications and be tracked through authenticated logistics channels.
Pharmaceutical Preparation Manufacturing

POSTED

about 19 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
DIBUCAINE OINTMENTDIBUCAINE OINTMENT USP, containing 1 percent dibucaine as the active ingredient, is supplied in a collapsible tube with a rectal applicator and is intended for rectal administration only, classified for external use. Each unit of issue is a single package containing one ounce or 28 grams of the ointment, with a non-extendable shelf life of 36 months and storage requirements between 15 and 30 degrees Celsius (59 to 86 degrees Fahrenheit). The product is FDA-regulated and must comply with the DLA Master List of Technical and Quality Requirements, including MIL-STD-129 for marking and labeling, and packaging must adhere to RP001 for DLA procurement standards, with materials either packaged per IP025 if hazardous or ASTM D3951 if not, prioritizing DLA specifications over commercial standards. The item is identified by NSN 6505002999535 and NDC 00536-1211-95, with a unit of issue in packages and quantity per unit pack of one. The contract SPE2DP-26-T-4234 specifies four separate line items totaling 11 packages, each priced at $2.00, with delivery due within 20 days of order, FOB destination, zero quantity variance allowed, and inspection and acceptance occurring at the delivery point. Shipments are directed to four distinct U.S. Navy vessel addresses in FPO locations, with explicit instructions to avoid parcel post and use only traceable freight methods via VSM. Required delivery dates span from May 29, 2026, to July 24, 2026, with specific RDD codes and project identifiers linked to each delivery. The product must be procured from the HARVARD DRUG GROUP, L.L.C., and all packaging, labeling, and shipping must strictly follow DLA technical and quality directives, including medical marking standards and palletization requirements, ensuring full compliance with federal procurement protocols.
Pharmaceutical Preparation Manufacturing

POSTED

about 19 hours ago

DEADLINE

in 5 days
View Details